BSEQualitek Labs LtdLowNeutral
Announced Fri, 26 Sept · 19:01 IST

As per the attached information

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Qualitek Labs Limited held its 7th Annual General Meeting on September 25, 2025, at 11:30 AM in New Delhi, concluding at 12:50 PM. Out of 893 shareholders on the record date, 13 attended in person (4 promoters, 9 public). All 7 resolutions were passed with the required majority, with 59,81,098 votes polled representing about 59.93% of total shares. Key items approved include adoption of FY25 audited financial statements, re-appointment of Mr. Kamal Grover as director, appointment of Mr. Mangesh Vitthal Bhosale as Whole-Time Director, appointment of Mr. Ajay Agarwal as Non-Executive Independent Director, increase in remuneration of Managing Director Mr. Antaryami Nayak, appointment of the Secretarial Auditor, and a hike in the overall remuneration limit for directors. The two remuneration-related resolutions saw token dissent of 1,200 votes (0.02%), while all other resolutions passed unanimously among polled votes.

Likely market impact

Routine procedural filing confirming shareholder approval of all AGM agenda items including new director appointments and higher director remuneration. The overwhelming support (nearly 100%) signals no meaningful shareholder dissent, so this is unlikely to move the stock price but does formalise board changes and expanded remuneration flexibility for the promoter-led management.